RCKT Stock Earnings: Rocket Pharmaceuticals Beats EPS for Q1 2024

    Date:

    Rocket Pharmaceuticals (NASDAQ:RCKT) just reported results for the first quarter of 2024.

    • Rocket Pharmaceuticals reported earnings per share of -66 cents. This was above the analyst estimate for EPS of -69 cents.
    • The company did not report any revenue for the quarter.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Go Source

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Elon Musk Weighs In On MAGA Divide, Urges GOP To Purge ‘Contemptible Fools’

    In the midst of the ongoing infighting within the...

    Azerbaijan Airlines Flight Hit by ‘External Interference’ Over Russia Before Fatal Crash

    An Azerbaijan Airlines flight which crashed on Christmas Day...

    Warren Buffett’s Stock Market Advice: Ignore Neighbor’s Whispers On Stock Tips, Focus On Long-Term Value

    In an interview with Fortune in 2013, legendary investor...